CoChat

Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews

Open access
Martis, Ruth, Brown, Julie, Alsweiler, Jane, Downie, Michelle R, Crowther, Caroline A · 2016 · Cochrane Database of Systematic Reviews
Cited by 88

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Successful treatments for gestational diabetes mellitus (GDM) have the potential to improve health outcomes for women with GDM and their babies. OBJECTIVES: To provide a comprehensive synthesis of evidence from Cochrane systematic reviews of the benefits and harms associated with interventions for treating GDM on women and their babies. METHODS: We searched the Cochrane Database of Systematic Reviews (5 January 2018) for reviews of treatment/management for women with GDM. Reviews of pregnant women with pre-existing diabetes were excluded.Two overview authors independently assessed reviews for inclusion, quality (AMSTAR; ROBIS), quality of evidence (GRADE), and extracted data. MAIN RESULTS: We included 14 reviews. Of these, 10 provided relevant high-quality and low-risk of bias data (AMSTAR and ROBIS) from 128 randomised controlled trials (RCTs), 27 comparisons, 17,984 women, 16,305 babies, and 1441 children. Evidence ranged from high- to very low-quality (GRADE). Only one effective intervention was found for treating women with GDM.EffectiveLifestyle versus usual careLifestyle intervention versus usual care probably reduces large-for-gestational age (risk ratio (RR) 0.60, 95% confidence interval (CI) 0.50 to 0.71; 6 RCTs, N = 2994; GRADE moderate-quality).PromisingNo evidence for any outcome for any comparison could be classified to this category.Ineffective or possibly harmful Lifestyle versus usual careLifestyle intervention versus usual care probably increases the risk of induction of labour (IOL) suggesting possible harm (average RR 1.20, 95% CI 0.99 to 1.46; 4 RCTs, N = 2699; GRADE moderate-quality).Exercise versus controlExercise intervention versus control for return to pre-pregnancy weight suggested ineffectiveness (body mass index, BMI) MD 0.11 kg/m², 95% CI -1.04 to 1.26; 3 RCTs, N = 254; GRADE moderate-quality).Insulin versus oral therapyInsulin intervention versus oral therapy probably increases the risk of IOL suggesting possible harm (RR 1.3, 95% CI 0.96 to 1.75; 3 RCTs, N = 348; GRADE moderate-quality).Probably ineffective or harmful interventionsInsulin versus oral therapyFor insulin compared to oral therapy there is probably an increased risk of the hypertensive disorders of pregnancy (RR 1.89, 95% CI 1.14 to 3.12; 4 RCTs, N = 1214; GRADE moderate-quality).InconclusiveLifestyle versus usual careThe evidence for childhood adiposity kg/m² (RR 0.91, 95% CI 0.75 to 1.11; 3 RCTs, N = 767; GRADE moderate-quality) and hypoglycaemia was inconclusive (average RR 0.99, 95% CI 0.65 to 1.52; 6 RCTs, N = 3000; GRADE moderate-quality).Exercise versus controlThe evidence for caesarean section (RR 0.86, 95% CI 0.63 to 1.16; 5 RCTs, N = 316; GRADE moderate quality) and perinatal death or serious morbidity composite was inconclusive (RR 0.56, 95% CI 0.12 to 2.61; 2 RCTs, N = 169; GRADE moderate-quality).Insulin versus oral therapyThe evidence for the following outcomes was inconclusive: pre-eclampsia (RR 1.14, 95% CI 0.86 to 1.52; 10 RCTs, N = 2060), caesarean section (RR 1.03, 95% CI 0.93 to 1.14; 17 RCTs, N = 1988), large-for-gestational age (average RR 1.01, 95% CI 0.76 to 1.35; 13 RCTs, N = 2352), and perinatal death or serious morbidity composite (RR 1.03; 95% CI 0.84 to 1.26; 2 RCTs, N = 760). GRADE assessment was moderate-quality for these outcomes.Insulin versus dietThe evidence for perinatal mortality was inconclusive (RR 0.74, 95% CI 0.41 to 1.33; 4 RCTs, N = 1137; GRADE moderate-quality).Insulin versus insulinThe evidence for insulin aspart versus lispro for risk of caesarean section was inconclusive (RR 1.00, 95% CI 0.91 to 1.09; 3 RCTs, N = 410; GRADE moderate quality).No conclusions possibleNo conclusions were possible for: lifestyle versus usual care (perineal trauma, postnatal depression, neonatal adiposity, number of antenatal visits/admissions); diet versus control (pre-eclampsia, caesarean section); myo-inositol versus placebo (hypoglycaemia); metformin versus glibenclamide (hypertensive disorders of pregnancy, pregnancy-induced hypertension, death or serious morbidity composite, insulin versus oral therapy (development of type 2 diabetes); intensive management versus routine care (IOL, large-for-gestational age); post- versus pre-prandial glucose monitoring (large-for-gestational age). The evidence ranged from moderate-, low- and very low-quality. AUTHORS' CONCLUSIONS: Currently there is insufficient high-quality evidence about the effects on health outcomes of relevance for women with GDM and their babies for many of the comparisons in this overview comparing treatment interventions for women with GDM. Lifestyle changes (including as a minimum healthy eating, physical activity and self-monitoring of blood sugar levels) was the only intervention that showed possible health improvements for women and their babies. Lifestyle interventions may result in fewer babies being large. Conversely, in terms of harms, lifestyle interventions may also increase the number of inductions. Tak

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd012327

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 175

  1. American College of Obstetricians and Gynecologists Committee on Practice Bulletins - Obstetrics, Practice Bulletin No. 137: Gestational diabetes mellitus, Obstetrics and Gynecology, 122, 406, 10.1097/01.AOG.0000433006.09219.f1 · DOI · Paper page
  2. American Diabetes Association, 2015, Management of diabetes in pregnancy. Standards of medical care in diabetes-2015, Diabetes Care, 38, S77, 10.2337/dc15-S015 · DOI
  3. Alwan, 2009, Treatments for gestational diabetes, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003395.pub2 · DOI · Paper page
  4. American Dietetic Association, 2001, Medical Nutrition Therapy Evidence Based Guides for Practice: Nutrition Practice Guidelines for Gestational Diabetes Mellitus
  5. Ansar, 2013, Safety of insulin glargine in pregnancy, Diabetes & Metabolism, 4, 240
  6. Arbit, 2004, The physiological rationale for oral insulin administration, Diabetes Technology Therapy, 6, 510, 10.1089/1520915041705929 · DOI · Paper page
  7. Artal, 2007, A lifestyle intervention of weight-gain restriction: diet and exercise in obese women with gestational diabetes mellitus, Applied Physiology Nutritional Metabolism, 32, 596, 10.1139/H07-024 · DOI · Paper page
  8. Asano, 2014, Acute effects of physical exercise in type 2 diabetes: A review, World Journal of Diabetes, 5, 659, 10.4239/wjd.v5.i5.659 · DOI · Paper page
  9. Asemi, 2014, Effects of calcium-vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial, Diabetologia, 57, 1798, 10.1007/s00125-014-3293-x · DOI
  10. Athukorala, 2010, The risk of adverse pregnancy outcomes in women who are overweight or obese, BMC Pregnancy and Childbirth, 10, 56, 10.1186/1471-2393-10-56 · DOI · Paper page
  11. Babio, 2010, Dietary fibre: influence on body weight, glycemic control and plasma cholesterol profile, Nutricion Hospitalaria, 25, 327
  12. Bagchi, 2015, Genomics, Proteomics and Metabolomics in Nutraceuticals and Functional Foods, 10.1002/9781118930458 · DOI
  13. Baljit, 2007, Psyllium as therapeutic and drug delivery agent, International Journal of Pharmaceutics, 334, 1, 10.1016/j.ijpharm.2007.01.028 · DOI · Paper page
  14. Balsells, 1997, Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes, Diabetes Care, 20, 172
  15. Bantle, 1983, Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects, New England Journal of Medicine, 309, 7, 10.1056/NEJM198307073090102 · DOI · Paper page
  16. Barakat, 2012, Exercise during pregnancy improves maternal glucose screen at 24-28 weeks: a randomised controlled trial, British Journal of Sports Medicine, 46, 656, 10.1136/bjsports-2011-090009 · DOI · Paper page
  17. Becker, 2011, Chapter 22: Overviews of reviews
  18. Berggren, 2013, Oral agents for the management of gestational diabetes, Clinical Obstetrics and Gynecology, 56, 827, 10.1097/GRF.0b013e3182a8e0a5 · DOI
  19. Bernasko, 2012, Insulin pump therapy for pregnancy: a primer, Journal of Maternal-Fetal and Neonatal Medicine, 25, 552, 10.3109/14767058.2011.598586 · DOI
  20. Bertini, 2005, Perinatal outcomes and the use of oral hypoglycemic agents, Journal of Perinatal Medicine, 33, 519, 10.1515/JPM.2005.092 · DOI · Paper page
  21. Bonomo, 2005, Evauating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized clinical trial, Diabetes Medicine, 22, 1536, 10.1111/j.1464-5491.2005.01690.x · DOI · Paper page
  22. Bottalico, 2007, Recurrent gestational diabetes: risk factors, diagnosis, management and implications, Seminars in Perinatology, 31, 176, 10.1053/j.semperi.2007.03.006 · DOI
  23. Broadhurst, 2006, Clinical studies on chromium picolinate supplementation in diabetes mellitus - a review, Diabetes Technology Therapeutics, 8, 677, 10.1089/dia.2006.8.677 · DOI · Paper page
  24. Brower, 1999, Nutraceuticals: poised for a healthy slice of the healthcare market?, Nature Biotechnology, 16, 728, 10.1038/nbt0898-728 · DOI · Paper page
  25. Buchanan, 1991, Glucose metabolism during pregnancy: normal physiology and implication for diabetes mellitus, Israel Journal of Mecial Science, 29, 432
  26. Burris, 2012, Vitamin D deficiency in pregnancy and gestational diabetes mellitus, American Journal of Obstetric Gynecology, 207, 182 e1-8, 10.1016/j.ajog.2012.05.022 · DOI · Paper page
  27. Callesen, 2013, Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome, Journal of Maternal, Fetal and Neonatal Medicine, 26, 588, 10.3109/14767058.2012.743523 · DOI · Paper page
  28. Carino, 1999, Oral insulin delivery, Advance Drug Delivery Review, 35, 249, 10.1016/S0169-409X(98)00075-1 · DOI · Paper page
  29. Carroll, 2015, In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin, Evidence Based Medicine, 20, 127, 10.1136/ebmed-2015-110186 · DOI
  30. Casey, 2015, Glyburide in women with mild gestational diabetes: A randomized controlled trial, Obstetrics & Gynecology, 126, 303, 10.1097/AOG.0000000000000967 · DOI · Paper page
  31. Chalmers, 1989, Materials and methods used in synthesizing evidence to evaluate the effects of care during pregnancy & childbirth, 2, 39
  32. Chan, 2005, Placental transfer of rosiglitazone in the first trimester of human pregnancy, Fertility and Sterility, 83, 955, 10.1016/j.fertnstert.2004.10.045 · DOI
  33. Cheung, 2003, Population health significance of gestational diabetes, Diabetes Care, 26, 2005, 10.2337/diacare.26.7.2005 · DOI · Paper page
  34. Cheung, 2009, The management of gestational diabetes, Vascular Health and Risk Management, 5, 153, 10.2147/VHRM.S3405 · DOI · Paper page
  35. Christesen, 1998, Prolonged elimination of tolbutamide in a premature newborn with hyperinsulinaemic hypoglycaemia, European Journal of Endocrinology, 138, 698, 10.1530/eje.0.1380698 · DOI
  36. Clapp, 2002, Maternal carbohydrate intake and pregnancy outcome, Proceedings of the Nutrition Society, 61, 45, 10.1079/PNS2001129 · DOI · Paper page
  37. Clapp, 2006, Effects of diet and exercise on insulin resistance during pregnancy, Metabolic Syndrome and Related Disorders, 4, 84, 10.1089/met.2006.4.84 · DOI · Paper page
  38. Coderre, 1995, Identification and characterization of an exercise-sensitive pool of glucose transporters in skeletal muscle, Journal of Biological Chemistry, 270, 27584, 10.1074/jbc.270.46.27584 · DOI · Paper page
  39. Coiner, 2014, The treatment of diabetes in pregnancy; metformin vs glyburide and insulin - biomedical evidence of fetopathy, American Journal of Obstetrics and Gynecology, 1 Suppl, S148, 10.1016/j.ajog.2013.10.314 · DOI
  40. Coleman, 2001, The therapeutic use of lipoic acid in diabetes: a current perspective, Environmental Toxicology and Pharmacology, 10, 167, 10.1016/S1382-6689(01)00080-1 · DOI
  41. Crawford, 2015, Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD011507.pub2 · DOI · Paper page
  42. Croze, 2013, Potential role and therapeutic interests of myo-inositol in metabolic diseases, Biochimie, 95, 1811, 10.1016/j.biochi.2013.05.011 · DOI · Paper page
  43. D’Anna, 2013, Myo-inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study, Diabetes Care 2013, 36, 854
  44. D’Anna, 2015, Myo-Inositol supplementation for prevention of gestational diabetes in obese pregnant women. A randomized controlled trial, Obstetrics, 126, 310, 10.1097/AOG.0000000000000958 · DOI · Paper page
  45. Davenport, 2008, A walking intervention improves capillary glucose control in women with gestational diabetes mellitus: a pilot study, Applied Physiology, Nutrition, and Metabolism, 33, 511, 10.1139/H08-018 · DOI · Paper page
  46. Barros, 2010, Resistance exercise and glycemic control in women with gestational diabetes mellitus, American Journal of Obstetrics and Gynecology, 203, 556 e1-e6, 10.1016/j.ajog.2010.07.015 · DOI
  47. Devlieger, 2008, Reduced adaptation of the pancreatic B cells during pregnancy is the major causal factor for gestational diabetes: current knowledge and metabolic effects on the offspring, Acta Obstetricia et Gynecologica Scandinavica, 87, 1266, 10.1080/00016340802443863 · DOI · Paper page
  48. Dornhorst, 2002, The principles of dietary management of gestational diabetes: reflection on current evidence, Journal of Human Nutrition and Dietetics, 15, 145, 10.1046/j.1365-277X.2002.00344.x · DOI · Paper page
  49. Dror, 2011, Vitamin D status during pregnancy: maternal, fetal, and postnatal outcomes, Current Opinion in Obstetrics and Gynecology, 23, 422, 10.1097/GCO.0b013e32834cb791 · DOI · Paper page
  50. Durnwald, 2013, Insulin analogues in the treatment of gestational diabetes mellitus, Clinical Obstetric and Gynecology, 56, 816, 10.1097/GRF.0b013e3182a8e03f · DOI
  51. Egerman, 2009, Perinatal outcomes in pregnancies managed with antenatal insulin glargine, American Journal of Perinatology, 26, 591, 10.1055/s-0029-1220782 · DOI · Paper page
  52. Elliott, 1991, Insignificant transfer of glyburide occurs across the human placenta, American Journal of Obstetrics and Gynecology, 165, 807, 10.1016/0002-9378(91)90421-M · DOI · Paper page
  53. England, 2015, Estimating the recurrence rate of gestational diabetes mellitus (GDM) in Massachusetts 1998-2007: Methods and findings, Maternal Child Health Journal, 19, 2303, 10.1007/s10995-015-1750-x · DOI
  54. Eskin, 2005, Dictionary of Nutraceuticals and Functional Foods, 10.1201/9780203486856 · DOI
  55. Evans, 2009, Diabetes and pregnancy: a review of pathology, British Journal of Diabetes & Vascular Disease, 9, 201, 10.1177/1474651409344924 · DOI
  56. Facchinetti, 2013, Myoinositol supplementation in pregnancies at risk for gestational diabetes. Interim analysis of a randomized controlled trial, American Journal of Obstetrics and Gynecology, 208, S36, 10.1016/j.ajog.2012.10.234 · DOI
  57. Gabbe, 2000, Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus, American Journal of Obstetrics and Gynecology, 182, 1283, 10.1067/mob.2000.106182 · DOI
  58. Gamson, 2004, The safety and efficacy of insulin analogs in pregnancy, Journal of Maternal-Fetal and Neonatal Medicine, 15, 26, 10.1080/14767050310001650680 · DOI
  59. Garrison, 2015, Screening, diagnosis and management of gestational diabetes mellitus, Amercian Family Physician, 91, 460
  60. Goldberg, 1998, A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes, Diabetes Care, 21, 1897, 10.2337/diacare.21.11.1897 · DOI · Paper page
  61. Gonzalez, 2002, Management of diabetes in pregnancy, Clinical Obstetrics and Gynecology, 45, 165, 10.1097/00003081-200203000-00016 · DOI
  62. Graves, 2006, The use of insulin glargine with gestational diabetes mellitus, Diabetes Care, 29, 471, 10.2337/diacare.29.02.06.dc05-2042 · DOI · Paper page
  63. Groop, 1987, Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects, Diabetes, 36, 1320, 10.2337/diab.36.11.1320 · DOI · Paper page
  64. Groop, 1991, Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans, Diabetes Care, 14, 724, 10.2337/diacare.14.8.724 · DOI · Paper page
  65. Grunberger, 2013, The need for better insulin therapy, Diabetes, Obesity and Metabolism, 15, 1, 10.1111/dom.12061 · DOI
  66. Guerrero-Romero, 2004, Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial, Diabetes Metabolism, 30, 253, 10.1016/S1262-3636(07)70116-7 · DOI · Paper page
  67. Gupta, 2010, An overview of nutraceuticals: current scenario, Journal of Basic and Clinical Pharmacy, 1, 55
  68. Hamid, 2000, Functional properties of dietary fibre prepared from defatted rice bran, Food Chemistry, 68, 15, 10.1016/S0308-8146(99)00145-4 · DOI · Paper page
  69. Han, 2013, Different types of dietary advice for women with gestational diabetes mellitus, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD009275.pub2 · DOI · Paper page
  70. Harris, 1997, The epidemiology of diabetes in pregnant native Canadians: A risk profile, Diabetes Care, 20, 1422, 10.2337/diacare.20.9.1422 · DOI · Paper page
  71. Harries, 2005, Diabetes management and exercise in pregnant patients with diabetes, Cinical Diabetes, 23, 165, 10.2337/diaclin.23.4.165 · DOI
  72. Harris, 2013, Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial, Lancet, 382, 2077, 10.1016/S0140-6736(13)61645-1 · DOI · Paper page
  73. Hartman, 2008, Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence, Clinical Medcial Research, 6, 54, 10.3121/cmr.2008.793 · DOI
  74. Hay WW, 2006, Placental-fetal glucose exchange and fetal glucose metabolism, Transactions of the American Clinical and Climatological Association, 117, 321
  75. Hedderson, 2006, Pregnancy weight gain and risk of neonatal complications: Macrosomia, hypoglycemia, and hyperbilirubinemia, Obstetrics & Gynecology, 108, 1153, 10.1097/01.AOG.0000242568.75785.68 · DOI · Paper page
  76. Heinemann, 2011, New ways of insulin delivery, International Journal of Clinical Practice Supplement, 170, 31, 10.1111/j.1742-1241.2010.02577.x · DOI · Paper page
  77. Ho, 2007, Oral hypoglycaemic agents for diabetes in pregnancy - an appraisal of the current evidence for oral anti-diabetic drug use in pregnancy, Annals Academy of Medicine, 36, 672
  78. Hod M For the Novorapid insulin trial of the safety and efficacy of insulin Aspart for the treatment of Type 1 Diabetic Women during Pregnancy: Study design Conference Proceedings. European Association for the Study of Diabetes 2005
  79. Hod, 2014, A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes, Journal of Maternal, Fetal and Neonatal Medicine, 27, 7, 10.3109/14767058.2013.799650 · DOI · Paper page
  80. Hollander, 2010, Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes, Diabetes Technology Therapy, 12, 185, 10.1089/dia.2009.0114 · DOI
  81. Holt, 2013, The use of oral hypoglycaemic agents in pregnancy, Diabetic Medicine, 31, 282, 10.1111/dme.12376 · DOI · Paper page
  82. Home, 2015, Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?, Diabetes, Obesity and Metabolism, 17, 1011, 10.1111/dom.12501 · DOI · Paper page
  83. Hompesh, 2009, Glycaemic exposure is affected favourably by inhaled human insulin (Exubera) as compared with subcutaneous insulin glargine (Lantus) in patients with type 2 diabetes, Diabetes Technology Therapy, 11, 307, 10.1089/dia.2008.0080 · DOI
  84. Hui, 2009, Hypoglycemic herbs and their action mechanisms, Chinese Medicine - BioMedCentral, 4, 11, 10.1186/1749-8546-4-11 · DOI · Paper page
  85. Iyer, 2010, Oral insulin - a review of current status, Diabetes, Obesity and Metabolism, 12, 179, 10.1111/j.1463-1326.2009.01150.x · DOI
  86. Jones, 2012, Pain management for women in labour: an overview of systematic reviews, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD009234.pub2 · DOI · Paper page
  87. Jovanovic, 2007, Treatment with insulin and its analogs in pregnancies complicated by diabetes, Diabetes Care, 30, 220, 10.2337/dc07-s220 · DOI · Paper page
  88. Kalra, 2015, Use of oral anti-diabetic agents in pregnancy: A pragmatic approach, North American Journal of Medicine & Science, 7, 6, 10.4103/1947-2714.150081 · DOI · Paper page
  89. Kavitha, 2013, Oral hypoglycemic agents in pregnancy: An update, Journal of Obstetrics and Gynecology of India, 63, 82, 10.1007/s13224-012-0312-z · DOI
  90. Kelley, 2015, A review of current treatment strategies for gestational diabetes mellitus, Drugs in Context, 4, 212282, 10.7573/dic.212282 · DOI · Paper page
  91. Kemball, 1970, Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy, Archives of Disease in Childhood, 45, 696, 10.1136/adc.45.243.696 · DOI · Paper page
  92. Kershaw, 2006, Adipose triglyceride lipase function, regulation by insulin, and comparison with adiponutrin, Diabetes, 55, 148, 10.2337/diabetes.55.01.06.db05-0982 · doi:10.2337/diabetes.55.01.06.db05-0982 · Paper page
  93. Kim, 2010, Gestational diabetes: risks, management, and treatment options, International Journal of Women’s Health, 7, 339, 10.2147/IJWH.S13333 · DOI · Paper page
  94. Kraemer, 2006, Perfusion studies of glyburide transfer across the human placenta: Implications for fetal safety, American Journal of Obstetrics and Gynecology, 195, 270, 10.1016/j.ajog.2005.12.005 · DOI
  95. Lain, 2007, Metabolic changes in pregnancy, Clinical Obstetrics and Gynecology, 50, 938, 10.1097/GRF.0b013e31815a5494 · DOI · Paper page
  96. LakshmanaPrabu, 2012, Nutraceuticals: A review, Elixir Pharmacy, 46, 8372
  97. Langer, 2007, Oral anti-hyperglycemic agents for the management of gestational diabetes mellitus, Obstetrics & Gynecology Clinics of North America, 34, 255, 10.1016/j.ogc.2007.03.004 · DOI
  98. Lapolla, 2005, Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?, Diabetes Metabolism Research Review, 21, 241, 10.1002/dmrr.551 · DOI · Paper page
  99. Larner, 2010, D-Chiro-Inositol glycans in insulin signalling and insulin resistance, Molecular Medicine, 16, 543, 10.2119/molmed.2010.00107 · DOI · Paper page
  100. Lebovitz, 1997, Alpha-glucosidase inhibitors, Endocrinology Metababolism Clinical North America, 26, 539, 10.1016/S0889-8529(05)70266-8 · DOI · Paper page
  101. Louie, 2011, A randomized controlled trial investigating the effects of a low-glycemic index diet on pregnancy outcomes in gestational diabetes mellitus, Diabetes Care, 34, 2341, 10.2337/dc11-0985 · DOI · Paper page
  102. Lucas, 1988, Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia, BMJ Clinical Research, 297, 1304, 10.1136/bmj.297.6659.1304 · DOI · Paper page
  103. Malvasi, 2014, Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation, European Review for Medical and Pharmacological Sciences, 18, 270
  104. Martin, 2006, Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes, Diabetes Care, 29, 1826, 10.2337/dc06-0254 · DOI · Paper page
  105. McCance, 2011, Pregnancy and diabetes, Best Practice & Research Clinical Endocrinology & Metabolism, 25, 945, 10.1016/j.beem.2011.07.009 · DOI
  106. Menon, 1990, Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus, New EngIand Journal of Medicine, 323, 309, 10.1056/NEJM199008023230505 · DOI · Paper page
  107. Metzger, 2008, Hyperglycemia and adverse pregnancy outcomes, New England Journal of Medicine, 358, 1991, 10.1056/NEJMoa0707943 · DOI · Paper page
  108. Mokdad, 2003, Prevalence of obesity, diabetes and obesity-related health risk factors, 2001, JAMA, 289, 76, 10.1001/jama.289.1.76 · DOI · Paper page
  109. Mooren, 2011, Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial, Diabetes Obesity Metabolism, 13, 281, 10.1111/j.1463-1326.2010.01332.x · DOI · Paper page
  110. Moretti, 2008, Safety of glyburide for gestational diabetes: A meta-analysis of pregnancy outcome, Annals of Pharmacotherapy, 42, 483, 10.1345/aph.1K577 · DOI · Paper page
  111. Moses, 2009, Can a low-glycemic index diet reduce the need for insulin in gestational diabetes mellitus? A randomized trial, Diabetes Care, 32, 996, 10.2337/dc09-0007 · DOI · Paper page
  112. Mottola, 2008, The role of exercise in the prevention and treatment of gestational diabetes mellitus, Current Diabetes Reports, 8, 299, 10.1007/s11892-008-0053-7 · DOI
  113. Mpondo, 2015, Gestational diabetes mellitus: challenges in diagnosis and management, Journal of Diabetes and Metabolic Disorders, 14, 42, 10.1186/s40200-015-0169-7 · DOI
  114. Nachum, 1999, Twice daily insulin versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial, BMJ, 319, 1223, 10.1136/bmj.319.7219.1223 · DOI · Paper page
  115. Nankervis, 2013, Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes Mellitus in Australia
  116. Negrato, 2012, Insulin analogues in the treatment of diabetes in pregnancy, Arquivos Brasileiros de Endocrinologia & Metabologia, 56, 405, 10.1590/S0004-27302012000700001 · DOI
  117. National Institute for Health and Clinical Excellence, 2015, Diabetes in Pregnancy: Management of Diabetes and its Complications from Preconception to the Postnatal Period. NICE Guideline NG3
  118. Nuttall, 1984, Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load, Diabetes Care, 7, 465, 10.2337/diacare.7.5.465 · DOI · Paper page
  119. NZ Ministry of Health, 2014, Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline
  120. Ogunyemi, 2011, Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Study group (IADPSG), Diabetes Medicine, 28, 976, 10.1111/j.1464-5491.2011.03326.x · DOI · Paper page
  121. Ornoy, 2005, Growth and neurodevelopment outcome of children born to mothers with pre-gestational and gestational diabetes, Pediatric Endocrinology Reviews, 3, 104
  122. Ornoy, 2011, Prenatal origin of obesity and their complications: Gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia, Reproductive Toxicology, 32, 205, 10.1016/j.reprotox.2011.05.002 · DOI · Paper page
  123. Padayachee, 2015, Exercise guidelines for gestational diabetes mellitus, World Journal of Diabetes, 6, 1033, 10.4239/wjd.v6.i8.1033 · DOI
  124. Page, 2014, Gestational diabetes mellitus, maternal obesity and adiposity in offspring, Journal of Pediatrics, 164, 807, 10.1016/j.jpeds.2013.11.063 · DOI · Paper page
  125. Paivaa, 2015, Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study, Journal of Trace Elements in Medicine and Biology, 32, 66, 10.1016/j.jtemb.2015.05.006 · DOI
  126. Petry, 2010, Gestational diabetes: risk factors and recent advances in its genetics and treatment, British Journal of Nutrition, 6, 1
  127. Pollex, 2011, Safety of insulin Glargine use in pregnancy. A systematic review and meta-analysis, Annals of Pharmacotherapy, 45, 9, 10.1345/aph.1P327 · DOI · Paper page
  128. Poomalar, 2015, Changing trends in management of gestational diabetes mellitus, World Journal of Diabetes, 6, 284, 10.4239/wjd.v6.i2.284 · DOI · Paper page
  129. Price, 2007, Use of insulin glargine during pregnancy: a case-control pilot study, British Journal of Obstetrics and Gynaecology, 114, 453, 10.1111/j.1471-0528.2006.01216.x · DOI · Paper page
  130. Proud, 2006, Regulation of protein synthesis by insulin, Biochemical Society Transaction, 34, 213, 10.1042/BST0340213 · DOI · Paper page
  131. Radesky, 2008, Diet during early pregnancy and development of gestational diabetes, Paediatric and Perinatal Epidemiology, 22, 47, 10.1111/j.1365-3016.2007.00899.x · DOI · Paper page
  132. Rae, 2000, A randomised controlled trial of dietary energy restriction in the management of obese women with gestational diabetes, Australian and New Zealand Journal of Obstetrics and Gynaecology, 40, 416, 10.1111/j.1479-828X.2000.tb01172.x · DOI · Paper page
  133. Ragnarsdottir, 2010, Development of macrosomia resulting from gestational diabetes mellitus: physiology and social determinants of health, Advances in Neonatal Care, 10, 7, 10.1097/ANC.0b013e3181bc8559 · DOI
  134. Rajasekaran, 2008, Nutraceuticals as therapeutic agents: A Review, Research Journal of Pharmacy and Technology, 1, 328
  135. Rendell, 2004, Advances in diabetes for the millennium: Drug therapy of type 2 diabetes, Medscape General Medicine, 6, 9
  136. Rose, 2005, Skeletal muscle glucose uptake during exercise: how is it regulated?, Physiology (Bethesda), 20, 260, 10.1152/physiol.00012.2005 · DOI · Paper page
  137. Rosenberg, 2005, Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: Differences among four racial/ethnic groups, American Journal of Public Health, 95, 1545-51, 10.2105/AJPH.2005.065680 · DOI · Paper page
  138. Rosenstock, 2004, Repaglinide versus nateglinide monotherapy: A randomized multicenter study, Diabetes Care, 27, 1265, 10.2337/diacare.27.6.1265 · DOI · Paper page
  139. Rosenstock, 2009, Safety and efficacy of inhaled human insulin(Exubera) during discontinuation and re-administration of therapy in adults with type 2 diabetes: a 3-year randomised controlled trial, Diabetes Technology Therapy, 11, 697, 10.1089/dia.2009.0062 · DOI · Paper page
  140. Ryu, 2014, Gestational diabetes mellitus management with oral hypoglycemic agents, Seminars in Perinatology, 38, 508, 10.1053/j.semperi.2014.08.012 · DOI · Paper page
  141. Sadovsky, 2015, Placenta and placental transport function. Chapter 39, 2, 1741, 10.1016/B978-0-12-397175-3.01001-2 · DOI
  142. Sakamoto, 2002, Intracellular signaling in contracting skeletal muscle, Journal of Applied Physiology, 93, 369, 10.1152/japplphysiol.00167.2002 · DOI · Paper page
  143. Schneider, 2012, The prevalence of gestational diabetes in advanced economies, Journal of Perinatal Medicine, 40, 511, 10.1515/jpm-2012-0015 · DOI · Paper page
  144. Scwarz, 2013, Transplacental transfer of glyburide; is it clinically significant?, American Journal of Obstetrics and Gynecology, 208, S25
  145. Secher, 2010, Continuous glucose monitoring-enabled insulin-pump therapy in diabetic pregnancy, Acta Obstetricia et Gynecologica Scandinavica, 89, 1233, 10.3109/00016349.2010.498499 · DOI
  146. Serlin, 2009, Diagnosis and management of gestational diabetes mellitus, American Family Physician, 80, 57
  147. Shirazian, 2010, Lifestyle modification program decreases pregnancy weight gain in obese women, American Journal of Perinatology, 27, 411, 10.1055/s-0029-1243368 · DOI · Paper page
  148. Sigal, 2004, Physical activity/exercise and type 2 diabetes, Diabetes Care, 27, 2518, 10.2337/diacare.27.10.2518 · DOI · Paper page
  149. Simmons, 2001, Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community, Diabetes Care, 24, 2078-82, 10.2337/diacare.24.12.2078 · DOI · Paper page
  150. Simmons, 2015, Safety considerations with pharmacological treatment of gestational diabetes mellitus, Drug Safety, 38, 65, 10.1007/s40264-014-0253-9 · DOI
  151. Simonson, 1984, Mechanism of improvement of glucose metabolism after chronic glyburide therapy, Diabetes Care, 33, 828
  152. Singh, 2007, Insulin analogues in the treatment of diabetes in pregnancy, Obstetric and Gynecology Clinics of North America, 34, 275, 10.1016/j.ogc.2007.03.003 · DOI
  153. Sirtori, 1994, Re-evaluation of a biguanide, metformin: mechanism of action and tolerability, Pharmacological Research, 30, 187, 10.1016/1043-6618(94)80104-5 · DOI · Paper page
  154. Sirtori, 2002, N-3 fatty acids and diabetes, Biomedicine and Pharmacotherapy, 56, 397, 10.1016/S0753-3322(02)00255-X · DOI
  155. Stafne, 2012, Regular exercise during pregnancy to prevent gestational diabetes: a randomized controlled trial, Obstetrics & Gynecology, 119, 29, 10.1097/AOG.0b013e3182393f86 · DOI · Paper page
  156. Stumvoll, 2003, Thiazolidenedines - some recent development, Expert Opinion on Investigational Drugs, 12, 1179, 10.1517/13543784.12.7.1179 · DOI · Paper page
  157. Suffecool, 2015, Insulin detemir does not cross the human placenta, Diabetes Care, 38, e20, 10.2337/dc14-2090 · DOI · Paper page
  158. Suman Rao, 2013, In utero fuel homeostasis: Lessons for a clinician, Indian Journal of Endocrinology and Metabolism, 17, 60, 10.4103/2230-8210.107851 · DOI · Paper page
  159. Teh, 2011, Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines, Australian and New Zealand Journal of Obstetrics and Gynaecology, 51, 26, 10.1111/j.1479-828X.2011.01292.x · DOI · Paper page
  160. Thomas, 2005, American Dietetic Association Guide to Gestational Diabetes Mellitus
  161. Thomas, 2006, Nutrient intake of women with and without gestational diabetes with a specific focus on fatty acids, Nutrition, 22, 230, 10.1016/j.nut.2005.07.017 · DOI
  162. Tieu, 2010, Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007724.pub2 · DOI
  163. Wahlqvist, 1978, The effect of chain length on glucose absorption and the related metabolic response, American Journal of Clinical Nutrition, 31, 1998, 10.1093/ajcn/31.11.1998 · DOI
  164. Wang, 1996, Oral protein delivery, Journal of Drug Targeting, 4, 195, 10.3109/10611869608995624 · DOI
  165. Wang, 2013, Dietary magnesium intake improves insulin resistance among non-diabetic individuals with metabolic syndrome participating in a dietary trial, Nutrients, 5, 3010, 10.3390/nu5103910 · DOI · Paper page
  166. World Health Organization (WHO), 2013, Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. WHO/NMH/MND/13.2
  167. Wilcox, 2005, Insulin and insulin resistance, Clinical Biochemistry Review, 26, 19
  168. Wojtaszewski, 2002, Effect of acute exercise on insulin signaling and action in humans, Journal of Applied Physiology, 93, 384, 10.1152/japplphysiol.00043.2002 · DOI · Paper page
  169. Wolff, 2008, A randomized trial of the effects of dietary counseling on gestational weight gain and glucose metabolism in obese pregnant women, International Journal of Obesity, 32, 495, 10.1038/sj.ijo.0803710 · DOI · Paper page
  170. Woodley, 1994, Enzymatic barriers for GI peptide and protein delivery, Critical Reviews in Therapeutic Drug Carrier Systems, 11, 61
  171. Woolderink, 2005, Use of insulin glargine during pregnancy in seven type 1 diabetic women, Diabetes Care, 28, 2594, 10.2337/diacare.28.10.2594 · DOI · Paper page
  172. Young, 2009, Diabetic medications in pregnancy, Current Diabetes Review, 5, 252, 10.2174/157339909789804350 · DOI
  173. Young, 2013, Fetal macrosomia and shoulder dystocia in women with gestational diabetes: risks amenable to treatment?, Current Diabetes Reports, 13, 12, 10.1007/s11892-012-0338-8 · DOI
  174. Zeisel, 1999, Regulation of nutraceuticals, Science, 285, 1853, 10.1126/science.285.5435.1853 · DOI · Paper page
  175. Zhang, 2010, Risk factors for gestational diabetes: from an epidemiological standpoint, 71, 10.1007/978-1-84882-120-0_5 · DOI · Paper page

Cited by

See all 88

Metadata

Authors
Martis, R., Brown, J., Alsweiler, J., Downie, M. R., & Crowther, C. A.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2016-08-31
Volume
8
Pages
CD012327-CD012327
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W2512282875
Cited by
88
References
48
FWCI
0.78
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. https://app.cochat.ai/papers/10.1002/14651858.cd012327
The paper
Martis, R., Brown, J., Alsweiler, J., Downie, M. R., & Crowther, C. A. (2016). Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd012327

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.